Objective: To provide evidence regarding existing partnerships between academic pharmacy and primary care that focus on training practitioners in patient-centered health care (PCHC).
P rimary care is arguably the cornerstone of the U.S. health care system and generally how patients first access the medical system for care. In the primary care system, physicians often are responsible for managing and coordinating the care of patients and treating a variety of complaints, ranging from uncomplicated respiratory infections to complications arising from chronic diseases such as diabetes. 1 Unfortunately, of all specialty areas in medicine, primary care is predicted to have the greatest shortage of physicians by 2025, with a predicted decline of approximately 46,000 physicians. Such a shortage may translate into longer waiting times for appointments, shorter patient visits with providers, and/or increased commute times for receiving care, which may lead to negative patient outcomes and/or provider stress. Such outcomes also may exacerbate the physician shortage problem and negatively affect patient care in the United States. 2 To help counteract this physician supply deficit, a number of strategies must be used. One important strategy is to reduce the demand on physicians and primary care services. The cur-
At a Glance
Synopsis: Based on analysis of the 2009-10 American Association of Colleges of Pharmacy Professional Affairs Committee report, evidence is provided regarding pharmacist involvement in academic practice partnerships engaged in residency and experiential training, in order to advance these practice models for training and integration in the expansion of patientcentered health care (PCHC). Ambulatory care clinics were the most frequently reported health care delivery model, followed by Department of Veterans Affairs or military hospital clinics. Pharmacists worked alongside a variety of other health care providers in these settings. Collaboration occurred most commonly with family and internal medicine physicians but also with specialists such as psychiatrists, obstetricians/gynecologists, hematologists/oncologists, and other health care providers (e.g., nurses, physician assistants, dieticians, social workers).
Analysis: The manner in which PCHC will be structured and evolve, including the official composition of the health care team and type of reimbursement pharmacists might receive as a member of the team, remains to be informed following implementation of the Affordable Care Act. The increased demand for primary care services and the strong evidence base for pharmacist integration into primary care services signal the importance for developing strategies for pharmacist involvement in PCHC. The authors contend that by fostering communities of practice, identifying factors predicting successful implementation of pharmacy models of PCHC, and promoting initiatives to disseminate effective practice models, academic pharmacy can provide a valuable platform for advancing these efforts.
rent and future demands on the health care system created by the growth and aging of our population, changes related to the Affordable Care Act, and changes exacerbated by health profession workforce trends cannot be met by one profession alone. One way to accomplish this goal is to increase use of other health professionals, such as clinical pharmacists, as suggested by the American Association of Medical Colleges. 2 Student pharmacists and pharmacy residents are trained to provide patient-centered health care (PCHC) in accordance with the Joint Commission of Pharmacy Practitioners vision statement that "pharmacists will be the health care professional responsible for providing patient care that ensures optimal medication therapy outcomes."
3 Incorporating pharmacists into multidisciplinary, interprofessional health care settings alongside physicians, nurses, and other health professionals is essential to achieving this vision.
The 2009-10 Professional Affairs Committee (PAC) of the American Association of Colleges of Pharmacy (AACP) was tasked with examining the evidence for pharmacist integration into primary care practice and providing an analysis of current and potential care delivery models. PAC conducted a systematic review of the literature and issued a Call for Successful Practices to AACP membership. In total, 151 case reports were identified, including ambulatory care (n = 81 [54%]), integrated (n = 33 [22%]), community pharmacy (n = 29 [19%] ), or other (n = 8 [5%]) models. 4 A majority of the 151 reports noted some level of a relationship with a school or college of pharmacy, and 25 reports (16.6%) were models that included both residency training and experiential education at the site.
Objective
This commentary highlights pharmacist involvement in academic practice partnerships engaged in residency and experiential training, in order to advance these practice models for training and integration into the expansion of PCHC. This article is limited to an examination of pharmacists' roles in health care service delivery in the 25 reports identified (Table 1) . Describing academic pharmacy examples in other health care settings (e.g., acute, long term, hospice) and comparing these data with other service delivery models is beyond the scope of this commentary.
Educational infrastructure and training expectations
Standards and guidelines for experiential education and residency programs exist and support the pharmacist in PCHC. The Accreditation Council for Pharmacy Education (ACPE) emphasizes the importance for experiential education in pharmacy degree programs in standards 10, 13, and 14. 5 The Center for the Advancement of Pharmaceutical Education (CAPE) Educational Outcomes focus on three areas: pharmaceutical care, systems management, and public health. 6 The CAPE Educational Outcomes state that pharmaceutical care should be provided in cooperation with patients, prescribers, and other members of an interprofessional health care team. These educational outcomes combined with the ACPE standards have SPECIAL FEATURE ACADEMiC PHARMACy AND PCHC been a stimulus for the evolution of experiential education, resulting in expanded experiential educational programs, many of which are located in health care settings that provide collaborative opportunities for students to partner with academic pharmacists and other health care providers to provide PCHC.
The educational expectations of doctor of pharmacy degree (PharmD) programs focus on the provision of PCHC. Student pharmacists and pharmacy residents, in collaboration with clinician faculty preceptors, are available to address some of the gaps in patient care. Further exploration of the postgraduate year (PGY)1 and PGY2 pharmacy residency training programs is important. The American Society of Health-System Pharmacists advocates residency training as the best source of training highly qualified pharmacy manpower. 7, 8 The educational outcomes of PGY1 programs include a concerted focus on training pharmacy graduates to provide care in PCHC models. 9 Outcome R2 of the PGY1 Accreditation Standards requires pharmacy residents to provide evidence-based, patientcentered medication therapy management (MTM) in interdisciplinary teams. This outcome highlights that the next generation of residency-trained pharmacists are oriented to practice in collaborative and PCHC models of care. With academic pharmacy meeting the ACPE standards and CAPE Educational Outcomes regarding practice in PCHC models for experiential education, as well as offering pharmacy residencies meeting the standards for focused training in PCHC models, academic pharmacy provides a critical mass of pharmacists ready to learn and practice in PCHC models and address primary care needs as they pertain to medication management.
Academic pharmacy and PCHC
Evidence of the pharmacist's role in primary care was summarized in the 2009-10 AACP PAC report. 4 A total of 151 unique reports were identified. Primarily descriptive reports of practice models involving pharmacists providing PCHC, most reports included PCHC related to management of prevalent chronic primary care diseases (e.g., diabetes, hypertension, dyslipidemia). Frequent settings for the provision of care were community pharmacies (19% of reports) and ambulatory care clinics (54% of reports). Although dispensing functions were included in many reports, other patient care services consisted of MTM services, disease management services, and educational programs. The majority described collaboration between pharmacists, physicians, and/or other health professionals, while others also alluded to the use of protocols or other guidelines to direct clinical care. PCHC was reported in rural, urban, and suburban geographical areas.
Nearly every model from the PAC report described clinical outcomes as the key component of its results. Of the 137 reports evaluating clinical outcomes, more than 60% demonstrated improved outcomes. A total of 66 reports evaluated humanistic outcomes and general demonstrated improvements in patient satisfaction, quality of life, and/or patient knowledge. Of the 33 reports evaluating economic outcomes, greater than 50% demonstrated reductions in medication costs, medical costs, or visits to the emergency department. Overall, the evidence demonstrates that these models of care are beneficial through improving control of chronic diseases, appropriate use of pharmacotherapy, and/or promotion of health and wellness.
To further examine clinical training for the next generation of pharmacists for PCHC, this commentary narrowed its review to include only those programs that participated in both residency training and experiential education for providing PCHC. When examining these reports of PCHC extracted from the PAC report (Table 1) , several relevant themes emerged. First, most of these cases described a multidisciplinary, collaborative effort for the provision of patient care. The most frequently reported practice environment was an ambulatory care clinic (84% of reports). These pharmacists worked alongside a variety of other health care providers, most commonly physicians (84% of reports). Other health care provider collaborators included various nursing specialties (44%), social workers (24%), physician assistants (16%), and nutritionists (8%).
The majority of the programs from the narrowed pool involved academic connections beyond the experiential education realm. Pharmacy faculty members were patient service providers in 76% of the reports and served as research investigators in 68% of cases. Pharmacy educators clearly are taking an active role not only in direct patient care in primary care settings but also in disseminating information concerning the impact of such services.
Within the narrowed pool of reports, a variety of quantitative and qualitative outcomes were examined to determine the impact of pharmacists' integration into the PCHC team. Outcomes most frequently included quality of life (64% of reports), improved medication adherence (56% of reports), and those specific to MTM (48% of reports). Patient results were consistently favorable in these reports and included improved patient care outcome measures (e.g., decreased glycosylated hemoglobin, increased medication adherence and awareness, decreased hospital readmissions, improved cholesterol levels).
From the analysis of findings in Table 1 , PCHC that included academic pharmacists, student pharmacists, and pharmacy residents consistently resulted in improved patient satisfaction and outcomes, frequently at a reduced cost to the health care system. A redeployment of workforce within the PCHC team also was reported as, for example, physician time became available for more patient encounters if pharmacotherapy management was moved to a pharmacist service. Because the majority of the settings were ambulatory care clinics, the implementation and/or expansion of pharmacist services in these settings appears to be particularly appropriate and most readily financially justifiable. Likewise, although improved outcomes were documented in a variety of diseases (e.g., human immunodeficiency virus, depression), improved outcomes related to diabetes, hypertension, and dyslipidemia were reported most often. It is perhaps reasonable, therefore, for the pharmacy profession to consider targeting these prevalent chronic diseases as a vehicle for expanding the role of pharmacists in PCHC. A m e r i c a n P h a r m a c i s t s A s s o c i a t i Description of a practice model in a university-based clinic that serves geriatric patients in collaboration with an interdisciplinary team. Clinic staff include 5 geriatricians, a fellow in geriatric medicine, a PA, 2 neuropsychologists, 2 clinical pharmacists, a social worker, a neurologist, a rheumatologist, and a rehabilitation specialist; academic health center support from geriatrics program; pharmacists fully integrated in the practice; a time-based facility fee is charged; patient encounters documented using pharmacist CPT codes; centralized appointment scheduling; all pharmacist activities generate a progress note; medical center funds 0.5-FTE pharmacist; facility fees and cash payments generated by the pharmacists help to offset the cost of a service; medical center marketing team promotes the pharmacy service to the community.
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Clinical, humanistic
SPECIAL FEATURE ACADEMiC PHARMACy AND PCHC Table 1 and nurses (NPs). 24 clinical pharmacists on all 7 primary care and multiple specialty care clinics; pharmacists located in provider rooms; bill using facility fee based on time and intensity; documentation in medical record; pharmacists are credentialed like physicians. ACADEMiC PHARMACy AND PCHC SPECIAL FEATURE
Ongoing challenges
As the Affordable Care Act transitions to implementation, the manner in which PCHC will ultimately be structured and evolve, including the official composition of the health care team and type of reimbursement pharmacists might receive as a member of the team, remains unknown. Because an increasing number of pharmacists are included in new roles in PCHC models, demand for pharmacists with specialty training will increase. Professional organizations have recognized this need and issued statements recommending postgraduate residency training for pharmacy graduates providing direct patient care by 2020. 10, 11 PharmD graduates are pursuing pharmacy residencies, particularly those emphasizing PCHC and roles in patient care teams, in record numbers. Currently, the number of graduates seeking residency training is greater than the number of available positions, and this gap continues to grow. 12 Meeting the demand is hindered by a lack of well-qualified preceptors in residency training programs. 13 The PCHC academic pharmacy training models described in this report are well suited to help fulfill this need; however, expansion is hindered by a shortage of faculty members to serve in these roles.
14,15
Future directions
In light of the increased demand for primary care services and the strong evidence base for pharmacists' integration into primary care services, developing strategies for promoting pharmacist integration into PCHC is essential. Academic pharmacy provides a valuable platform for these efforts, much as it did in the birth of clinical pharmacy. How can this be accomplished? Research related to practice development argues for efforts of three different types: (1) fostering communities of practice, (2) identifying factors predicting successful implementation of pharmacy models of PCHC, and (3) promoting initiatives to disseminate effective practice models.
The communities of practice described by Wenger and colleagues 16, 17 increasingly have come to be seen as meaningful, effective mechanisms for promoting knowledge transfer, 18, 19 performance improvement, 20 implementation of evidence-based practice, 21, 22 and interdisciplinary research collaboration. 23 Related to the engagement of student pharmacists and pharmacy residents, communities of practice also facilitate learning in the practice setting 24 and development of professional identity. 25, 26 As such, communities of practice offer considerable potential for capacity building by bolstering efforts of both expert and novice pharmacists in providing PCHC. Academic pharmacy provides one obvious venue for growing such communities to provide a way for practitioners to share tips and best practices, ask questions of their colleagues, and provide support for each other.
Research into factors that predict the adoption and success of pharmacy models of PCHC is a necessary complement to existing studies that assess outcomes. Such predictive studies could be carried out with and within communities of practice that develop into practice-based research networks. Implementation studies 27, 28 are needed to provide insight into variations in effectiveness of care processes. Similarly, studies identifying patient, provider, and contextual factors that affect adoption and success are essential for providing guidance regarding which model(s) of PCHC to implement, as well as the who, where, and how of implementation. The data analyzed for this commentary provide a launching point for such studies. Pharmacists reported that services were initiated often through an informal volunteer effort, which led to institutionalizing the service after value was demonstrated and relationships formalized. Similarly, documentation of pharmacist intervention and outcomes consistently was cited as an important factor, as was incorporation of the pharmacist documentation in the patient medical record. Expanding specific patient services from one site to other sites within the practice or expanding to other pharmacotherapeutic services within the practice occurred following positive evaluation of outcomes. Pharmacists repeatedly cited the importance of relationship building in these cases.
The current focus on translating results of comparative effectiveness into patient care 29, 30 points to the importance of designing initiatives specifically aimed at disseminating and implementing effective practice models. Such initiatives that promote pharmacist integration into PCHC can be designed in the absence of detailed information about factors that predict successful outcomes. Initiatives that rely on efforts of the current supply of pharmacists can be effective, as demonstrated by the "successful practice" reports discussed above. The scale of initiatives and their level of success are likely to be enhanced, however, if efforts are made to nurture additional patient-centered pharmacists and to identify what makes their practice models successful. Academic pharmacy provides a unique and valuable platform for these efforts.
Conclusion
As the demand for access to primary care services continues to grow, pharmacists have demonstrated an important contribution to PCHC. Innovative models of care delivery with pharmacists as integrated health care team members demonstrate improved patient health outcomes among other positive results. Serving as a comprehensive platform and communities of practice, academic pharmacy at PCHC sites featuring student pharmacists, pharmacy residents, preceptors, and academic pharmacy faculty members demonstrates a working model for training exemplary pharmacists in PCHC settings. To maximize these established partnerships and models available through academic pharmacy, pharmacy should foster these communities of practice, identify factors for the prediction of successful implementation of PCHC pharmacy models, and promote initiatives to disseminate effective practice models. Academic pharmacy has a demonstrated and valuable platform for enhancing and developing these efforts.
